Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Neurology. 2020 Oct 6;95(14):e1999-e2008. doi: 10.1212/WNL.0000000000010380. Epub 2020 Jul 29.
Neurology. 2020.
PMID: 32727835
Free PMC article.
Clinical Trial.